Alembic Pharmaceuticals has informed about a Press Release titled ‘Alembic and Orbicular establish ALEOR Dermaceuticals, a 60:40 joint venture to develop and commercialize dermatology products for global markets’.
The above information is a part of company’s filings submitted to BSE.